Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Sclerosis
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 288 active Multiple Sclerosis trials
A Study to Assess New Participant’s Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments
Study Type: Observational
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Study Type: Interventional Phase 1
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) – Multiple Sclerosis (MS)
Study Type: Interventional
Acute Effects of Walking Exercise on Brain Functioning in Multiple Sclerosis
Study Type: Interventional Early Phase 1
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Study Type: Interventional Phase 3
WOE of Anti-CD20 Therapies
Study Type: Observational
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Study Type: Interventional Phase 2
There are 288 active Multiple Sclerosis trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now